Choice Hotels International Inc. (CHH) is fresh off a quarter where more of its rooms were occupied and room rates were higher than a year ago. And for the operator of household name hotel brands such as Comfort Inn and Econo Lodge, the solid results came in spite of a mixed U.S. economy. ‘At the beginning of the year, you had a lot of people calling for robust GDP, particularly toward the end of the year,’ said Choice Hotels president and CEO Steve Joyce in an interview with TheStreet. According to Joyce, he didn’t sense a ‘groundswell building’ in the economy during the second quarter, but was quick to point out the hotel industry continues to hold up very well. And the industry’s resilience showed in the company’s latest results. Second quarter revenue for Choice Hotels increased 17% year over year to $232.2 million, beating consensus forecasts for $208.3 million. Earnings per share came in at $0.62, surpassing Wall Street’s estimates of $0.58. Revenue per available room (REVPAR), a key industry metric used to assess a hotel’s overall performance, rose 6.7% against the company’s guidance for 7%. Occupancy improved by 3.8%. The quarter was driven by Choice Hotels’ biggest brands in Comfort Inn and Quality, which collectively operate over 2,500 locations and represent about 200,000 rooms. TheStreet's Brian Sozzi reports from New York.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.